Regulation of the biosynthesis of N-acetylglucosaminylpyrophosphoryldolichol, feedback and product inhibition.
The assembly of the core oligosaccharide region of asparagine-linked glycoproteins proceeds by means of the dolichol pathway. The first step of this pathway, the reaction of dolichol phosphate with UDP-GlcNAc to form N-acetylglucosaminylpyrophosphoryldolichol (GlcNAc-P-P-dolichol), is under investigation as a possible site of metabolic regulation. This report describes feedback inhibition of this reaction by the second intermediate of the pathway, N-acetylglucosaminyl-N-acetylglucosaminylpyrophosphoryldolichol (GlcNAc-GlcNAc-P-P-dolichol), and product inhibition by GlcNAc-P-P-dolichol itself. These influences were revealed when the reactions were carried out in the presence of showdomycin, a nucleoside antibiotic, present at concentrations that block the de novo formation of GlcNAc-GlcNAc-P-P-dolichol but not that of GlcNAc-P-P-dolichol. The apparent K(i) values for GlcNAc-P-P-dolichol and GlcNAc-GlcNAc-P-P-dolichol under basal conditions were 4.4 and 2.8 microM, respectively. Inhibition was also observed under conditions where mannosyl-P-dolichol (Man-P-dol) stimulated the biosynthesis of GlcNAc-P-P-dolichol; the apparent K(i) values for GlcNAc-P-P-dolichol and GlcNAc-GlcNAc-P-P-dolichol were 2.2 and 11 microM, respectively. Kinetic analysis of the types of inhibition indicated competitive inhibition by GlcNAc-P-P-dolichol toward the substrate UDP-GlcNAc and non-competitive inhibition toward dolichol phosphate. Inhibition by GlcNAc-GlcNAc-P-P-dolichol was uncompetitive toward UDP-GlcNAc and competitive toward dolichol phosphate. A model is presented for the kinetic mechanism of the synthesis of GlcNAc-P-P-dolichol. GlcNAc-P-P-dolichol also exerts a stimulatory effect on the biosynthesis of Man-P-dol, i.e. a reciprocal relationship to that previously observed between these two intermediates of the dolichol pathway. This network of inhibitory and stimulatory influences may be aspects of metabolic control of the pathway and thus of glycoprotein biosynthesis in general.
Kean
E L
EL
Department of Ophthalmology, Case Western Reserve University, Cleveland, Ohio 44106, USA. elk2@po.cwru.edu
Wei
Z
Z
Anderson
V E
VE
Zhang
N
N
Sayre
L M
LM
D000117:Acetylglucosamine / Q000096:biosynthesis; D000143:Acids / Q000494:pharmacology; D000818:Animals; D002642:Chick Embryo; D004288:Dolichol Phosphates / Q000037:antagonists & inhibitors / Q000378:metabolism; D004286:Dolichols / Q000031:analogs & derivatives / Q000096:biosynthesis; D006868:Hydrolysis / Q000187:drug effects; D007700:Kinetics; D008055:Lipids / Q000096:biosynthesis; D008861:Microsomes / Q000187:drug effects / Q000378:metabolism; D011103:Polyisoprenyl Phosphate Monosaccharides / Q000037:antagonists & inhibitors* / Q000737:chemistry / Q000378:metabolism*; D011104:Polyisoprenyl Phosphate Oligosaccharides / Q000037:antagonists & inhibitors / Q000737:chemistry / Q000378:metabolism; D012160:Retina / Q000187:drug effects / Q000196:embryology / Q000378:metabolism; D012787:Showdomycin / Q000494:pharmacology; D017855:Transferases (Other Substituted Phosphate Groups) / Q000378:metabolism; D014316:Tritium; D014537:Uridine Diphosphate N-Acetylglucosamine / Q000037:antagonists & inhibitors / Q000378:metabolism; D014542:Uridine Monophosphate / Q000378:metabolism
D000143:Acids; D004288:Dolichol Phosphates; D004286:Dolichols; D008055:Lipids; D011103:Polyisoprenyl Phosphate Monosaccharides; D011104:Polyisoprenyl Phosphate Oligosaccharides; D014316:Tritium; D014537:Uridine Diphosphate N-Acetylglucosamine; C018439:N-acetylglucosaminylpyrophosphoryldolichol; C016418:dolichyl-diphosphate-di-N-acetylchitobiose; D012787:Showdomycin; D014542:Uridine Monophosphate; D017855:Transferases (Other Substituted Phosphate Groups); C023222:UDPacetylglucosamine-dolichyl-phosphate acetylglucosamine-1-phosphate transferase; D000117:Acetylglucosamine